Medisca Recalls Estriol USP Micronized Due to Failed Impurity Specifications
Medisca, Inc. is recalling specific lots of Estriol, USP (Micronized) because the product failed impurities and degradation specifications.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, which corresponds to a Severe rating under the rubric, particularly given the failure of impurity and degradation specifications for a pharmaceutical product.
Plain-English summary
Medisca, Inc. is recalling specific lots of Estriol, USP (Micronized) in various container sizes (1 g, 5 g, 25 g, 100 g, 2000 g, and 1 kg). The recall is being conducted because the product failed impurities and degradation specifications. The affected lots are #156110 A-P, #153328 A-D, and #161726 A-L.
The recall covers a total of 640,325 grams of the product, which was distributed nationwide. The product was packed by Medisca, Inc. in Plattsburgh, NY.
Consumers and healthcare providers should check their inventory for the specific lot numbers listed above. If you have these products, you should stop using them and contact Medisca, Inc. or your supplier for instructions on how to return or dispose of the recalled items.
The recalled product
- Product
- Estriol, USP (Micronized) 1 g, 5 g, 25 g, 100 g, 2000 g, 1 kg, containers, Packed by Medisca Inc., Plattsburgh, NY 12901, USA
- Manufacturer
- Medisca, Inc.
- Category
- Drug — Pharmaceutical Ingredient
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #156110 A-P Lot #153328 A-D Lot #161726 A-L
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Medisca, Inc.
See all →- ModerateBimatoprost Bulk Powder Recalled by Medisca for CGMP Deviations
FDA (Drugs) · 2025-04-30
- HighBudesonide USP drug ingredient recalled for glass contamination
FDA (Drugs) · 2024-07-10
- ModerateMedisca Recalls Aminocaproic Acid API Due to CGMP Labeling Deviations
FDA (Drugs) · 2017-09-27
- ModerateMedisca Recalls Estradiol API Due to cGMP Deviations
FDA (Drugs) · 2017-04-19
- SevereMedisca Recalls Estrone USP Bulk Due to cGMP Deviations
FDA (Drugs) · 2017-04-19
Same hazard · impurities
See all →- LowDabigatran Etexilate Capsules Recalled Due to Impurity Specification Failure
FDA (Drugs) · 2026-08-05
- ModerateGlycopyrrolate Oral Solution Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-29
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- ModerateMethohexital Sodium 100 mg/10 mL Compounded Drug Recalled Nationwide
FDA (Drugs) · 2026-07-15
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08